1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Muranyi, A.
Finn, B.E.
Gippert, G.P.
Forsen, S.
Stenflo, J.
Drakenberg, T.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
US
Biochemistry
BICHAW
0033
0006-2960
37
10605
10615
10.1021/bi980522f
9692950
Solution structure of the N-terminal EGF-like domain from human factor VII.
1998
UK
Nature
NATUAS
0006
0028-0836
380
41
The Crystal Structure of the Complex of Blood Coagulation Factor Viia with Soluble Tissue Factor
1996
US
Protein Sci.
PRCIEI
0795
0961-8368
1
81
The Three-Dimensional Structure of the First Egf-Like Module of Human Factor Ix: Comparison with Egf and Tgf-Alpha
1992
US
Biochemistry
BICHAW
0033
0006-2960
31
5974
Three-Dimensional Structure of the Apo Form of the N-Terminal Egf-Like Module of Blood Coagulation Factor X as Determined by NMR Spectroscopy and Simulated Folding
1992
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
4432.865
FACTOR VII
3.4.21.21
N-TERMINAL EGF-LIKE DOMAIN
1
man
polymer
no
no
SDGDQCASSPCQNGGSCKDQLQSYICFCLPAFEGRNCETHK
SDGDQCASSPCQNGGSCKDQLQSYICFCLPAFEGRNCETHK
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
Homo
sample
9606
BLOOD
Homo sapiens
pdbx_database_status
pdbx_struct_assembly
pdbx_struct_oper_list
struct_conf
struct_conf_type
repository
Initial release
Version format compliance
Version format compliance
Derived calculations
Other
1
0
1999-02-16
1
1
2008-03-24
1
2
2011-07-13
1
3
2017-11-29
_pdbx_database_status.process_site
Y
BNL
1998-05-28
REL
REL
NO DISTANCE RESTRAINT VIOLATED BY MORE THAN 0.2 ANGSTROM AND NO DIHEDRAL ANGLE RESTRAINTS VIOLATED BY MORE THAN 2 DEGREES
100
23
COSY
2Q
TOCSY
NOESY
NO SALT ADDED
5.6
1
atm
298
K
DISTANCE GEOMETRY EMBEDDING WITHOUT METRIZATION FOLLOWED BY RESTRAINED SIMULATED ANNEALING AND SIMULATED ANNEALING REFINEMENT
H2O AND D2O
BRUNGER
refinement
X-PLOR
3.1
structure solution
X-PLOR
500
GE
OMEGA
600
Varian
UNITYPLUS
SER
45
n
1
SER
45
A
ASP
46
n
2
ASP
46
A
GLY
47
n
3
GLY
47
A
ASP
48
n
4
ASP
48
A
GLN
49
n
5
GLN
49
A
CYS
50
n
6
CYS
50
A
ALA
51
n
7
ALA
51
A
SER
52
n
8
SER
52
A
SER
53
n
9
SER
53
A
PRO
54
n
10
PRO
54
A
CYS
55
n
11
CYS
55
A
GLN
56
n
12
GLN
56
A
ASN
57
n
13
ASN
57
A
GLY
58
n
14
GLY
58
A
GLY
59
n
15
GLY
59
A
SER
60
n
16
SER
60
A
CYS
61
n
17
CYS
61
A
LYS
62
n
18
LYS
62
A
ASP
63
n
19
ASP
63
A
GLN
64
n
20
GLN
64
A
LEU
65
n
21
LEU
65
A
GLN
66
n
22
GLN
66
A
SER
67
n
23
SER
67
A
TYR
68
n
24
TYR
68
A
ILE
69
n
25
ILE
69
A
CYS
70
n
26
CYS
70
A
PHE
71
n
27
PHE
71
A
CYS
72
n
28
CYS
72
A
LEU
73
n
29
LEU
73
A
PRO
74
n
30
PRO
74
A
ALA
75
n
31
ALA
75
A
PHE
76
n
32
PHE
76
A
GLU
77
n
33
GLU
77
A
GLY
78
n
34
GLY
78
A
ARG
79
n
35
ARG
79
A
ASN
80
n
36
ASN
80
A
CYS
81
n
37
CYS
81
A
GLU
82
n
38
GLU
82
A
THR
83
n
39
THR
83
A
HIS
84
n
40
HIS
84
A
LYS
85
n
41
LYS
85
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
identity operation
0.0000000000
0.0000000000
0.0000000000
1
A
ARG
79
0.245
SIDE CHAIN
2
A
ARG
79
0.296
SIDE CHAIN
3
A
ARG
79
0.309
SIDE CHAIN
4
A
ARG
79
0.200
SIDE CHAIN
5
A
ARG
79
0.252
SIDE CHAIN
6
A
ARG
79
0.180
SIDE CHAIN
7
A
ARG
79
0.231
SIDE CHAIN
8
A
ARG
79
0.307
SIDE CHAIN
9
A
ARG
79
0.183
SIDE CHAIN
10
A
ARG
79
0.282
SIDE CHAIN
11
A
ARG
79
0.293
SIDE CHAIN
12
A
ARG
79
0.304
SIDE CHAIN
13
A
ARG
79
0.158
SIDE CHAIN
14
A
ARG
79
0.246
SIDE CHAIN
15
A
ARG
79
0.317
SIDE CHAIN
16
A
ARG
79
0.129
SIDE CHAIN
17
A
ARG
79
0.287
SIDE CHAIN
18
A
ARG
79
0.317
SIDE CHAIN
19
A
ARG
79
0.291
SIDE CHAIN
20
A
ARG
79
0.266
SIDE CHAIN
21
A
ARG
79
0.282
SIDE CHAIN
22
A
ARG
79
0.089
SIDE CHAIN
23
A
ARG
79
0.307
SIDE CHAIN
1
A
ASP
46
61.74
109.49
1
A
CYS
50
-83.55
43.70
1
A
SER
53
50.91
70.49
1
A
GLN
64
-103.79
-165.64
1
A
SER
67
179.36
-112.44
1
A
CYS
72
-58.41
179.43
1
A
THR
83
-104.24
76.71
2
A
ASP
48
-60.91
-89.63
2
A
GLN
49
-129.15
-58.73
2
A
LEU
65
-51.02
-82.03
2
A
GLN
66
-36.18
-31.42
2
A
SER
67
169.91
-153.43
2
A
CYS
72
41.13
-159.53
3
A
GLN
49
40.53
-83.13
3
A
CYS
50
-80.79
43.23
3
A
SER
53
67.74
86.30
3
A
CYS
55
-42.45
151.69
3
A
SER
67
179.63
-134.90
3
A
CYS
72
-105.43
-160.53
3
A
GLU
77
-170.21
114.82
3
A
ASN
80
-152.20
19.54
3
A
THR
83
-118.04
75.82
4
A
ASP
48
-175.07
-83.64
4
A
SER
53
67.52
76.93
4
A
SER
67
-178.96
-131.13
4
A
CYS
72
-74.92
-159.27
4
A
ASN
80
-152.71
27.75
4
A
THR
83
-111.92
67.67
5
A
ASP
46
-179.37
-100.75
5
A
ASP
48
-176.50
-82.82
5
A
SER
52
-149.50
18.93
5
A
SER
53
54.29
72.60
5
A
SER
67
179.04
-123.59
5
A
CYS
72
-59.25
177.82
5
A
GLU
77
-167.22
113.82
5
A
ASN
80
-140.07
21.89
5
A
CYS
81
53.98
18.93
6
A
ASP
48
-178.19
-99.89
6
A
GLN
49
-130.43
-59.03
6
A
CYS
50
-81.57
41.22
6
A
SER
53
58.26
75.07
6
A
GLN
64
-106.79
-165.07
6
A
SER
67
-178.17
-132.90
6
A
CYS
72
-56.97
-175.37
6
A
GLU
77
-161.67
-36.14
6
A
THR
83
-103.97
66.41
6
A
HIS
84
-50.20
108.13
7
A
ASP
46
-163.31
-40.16
7
A
ASP
48
58.87
117.88
7
A
SER
53
58.97
77.46
7
A
SER
67
-165.44
-128.07
7
A
GLU
77
-160.72
86.59
8
A
GLN
49
45.67
-85.39
8
A
SER
53
69.49
74.07
8
A
SER
67
179.00
-136.12
8
A
CYS
72
-60.19
-172.67
8
A
GLU
77
-152.08
72.59
8
A
ASN
80
-140.67
24.41
8
A
HIS
84
-62.00
97.73
9
A
ASP
46
178.98
68.87
9
A
ASP
48
-94.00
-95.56
9
A
GLN
49
-139.36
-61.52
9
A
SER
52
-148.39
26.53
9
A
SER
53
45.13
72.64
9
A
SER
67
179.88
-118.24
9
A
CYS
72
-70.77
-164.87
9
A
ASN
80
-146.16
38.51
9
A
CYS
81
43.27
26.62
10
A
ASP
46
39.82
-161.98
10
A
CYS
50
-84.52
47.01
10
A
SER
52
-177.36
33.97
10
A
ASN
57
39.93
61.00
10
A
LEU
65
68.75
-82.81
10
A
SER
67
-146.12
-139.00
10
A
PHE
71
-140.03
-142.44
10
A
CYS
72
-179.69
-157.69
10
A
GLU
77
175.00
120.33
10
A
HIS
84
-61.02
92.96
11
A
ASP
48
-42.80
-93.27
11
A
GLN
49
-132.57
-67.26
11
A
SER
53
66.69
83.49
11
A
CYS
55
-41.95
159.55
11
A
SER
67
-177.91
-134.07
11
A
PHE
71
-150.91
77.01
11
A
CYS
72
-69.86
-152.84
11
A
GLU
77
-178.75
137.69
11
A
HIS
84
-43.62
105.52
12
A
GLN
49
71.00
-27.77
12
A
SER
53
67.44
71.20
12
A
LEU
65
-59.93
-76.17
12
A
GLN
66
-38.80
-39.17
12
A
SER
67
-177.09
-115.33
12
A
CYS
72
-79.47
-158.29
12
A
GLU
77
-172.75
75.12
12
A
ASN
80
-154.18
30.40
12
A
THR
83
-109.14
59.20
13
A
ASP
46
-137.10
-78.79
13
A
GLN
49
71.78
-34.15
13
A
SER
53
67.92
65.45
13
A
CYS
55
-43.06
165.62
13
A
GLN
64
-108.52
-155.31
13
A
LEU
65
-56.18
-112.89
13
A
GLN
66
-88.02
32.08
13
A
PHE
71
-137.30
-34.67
13
A
CYS
72
50.64
-157.29
13
A
GLU
77
-174.98
148.16
13
A
HIS
84
-45.92
107.07
14
A
ASP
46
177.04
-89.06
14
A
CYS
50
-84.06
40.35
14
A
SER
53
66.10
80.24
14
A
SER
67
-165.27
-132.09
14
A
CYS
72
-76.42
-152.46
14
A
GLU
77
-171.27
89.53
14
A
ASN
80
-154.01
29.42
14
A
THR
83
-106.60
57.78
15
A
ASP
46
-45.32
171.23
15
A
ASP
48
-88.28
-113.95
15
A
GLN
49
-133.72
-62.25
15
A
SER
52
-163.95
27.96
15
A
SER
67
-179.15
-133.69
15
A
CYS
72
-61.92
-178.32
15
A
CYS
81
55.43
17.35
16
A
ASP
48
58.63
117.49
16
A
SER
53
66.04
90.21
16
A
LEU
65
-43.33
-86.51
16
A
GLN
66
-35.66
-30.33
16
A
SER
67
170.60
-172.30
16
A
CYS
72
-74.08
-160.76
16
A
GLU
77
-171.11
107.27
16
A
ASN
80
-153.36
30.29
16
A
THR
83
-114.92
71.84
17
A
ASP
46
178.21
114.71
17
A
ASP
48
174.40
-28.99
17
A
GLN
49
47.16
-84.44
17
A
SER
52
-143.14
18.58
17
A
SER
53
68.74
76.10
17
A
LEU
65
-48.94
-79.63
17
A
GLN
66
-36.39
-34.20
17
A
SER
67
170.60
-154.00
17
A
CYS
72
-56.43
-160.81
17
A
GLU
77
-146.90
-42.83
18
A
ASP
46
64.78
64.74
18
A
ASP
48
171.23
-86.38
18
A
GLN
49
-131.95
-60.47
18
A
CYS
50
-83.39
42.21
18
A
ALA
51
-100.08
-63.57
18
A
SER
53
43.06
84.10
18
A
LEU
65
-49.74
-86.42
18
A
GLN
66
-36.00
-29.45
18
A
SER
67
169.24
-155.89
18
A
CYS
72
-56.48
-157.74
18
A
GLU
77
-160.23
69.58
18
A
THR
83
-105.21
58.70
19
A
ASP
48
-144.68
-90.28
19
A
GLN
49
-134.04
-50.00
19
A
SER
53
66.71
75.47
19
A
SER
67
179.66
-119.30
19
A
CYS
72
-86.36
-156.35
19
A
GLU
77
-137.65
-139.94
20
A
ASP
46
61.64
86.00
20
A
SER
53
68.64
66.77
20
A
CYS
55
-42.28
157.17
20
A
LEU
65
-51.72
-83.89
20
A
GLN
66
-35.56
-30.35
20
A
SER
67
169.50
-154.55
20
A
CYS
72
-83.10
-153.18
20
A
GLU
77
-170.35
132.32
20
A
ASN
80
-153.98
26.17
20
A
THR
83
-111.23
76.89
21
A
ASP
46
-144.88
11.92
21
A
SER
53
69.23
78.71
21
A
GLN
64
-107.56
-163.53
21
A
SER
67
-177.90
-123.25
21
A
GLU
77
-170.87
85.20
21
A
CYS
81
59.58
13.93
22
A
ASP
48
164.50
124.43
22
A
ALA
51
-93.92
-71.29
22
A
SER
53
64.96
77.05
22
A
LEU
65
68.10
-83.09
22
A
SER
67
-144.57
-156.06
22
A
CYS
72
-63.11
-170.89
22
A
GLU
77
-171.75
63.15
22
A
CYS
81
52.34
19.61
23
A
CYS
50
-83.99
44.54
23
A
SER
53
56.79
77.65
23
A
SER
67
178.79
-113.45
23
A
CYS
72
-61.65
-159.92
23
A
GLU
77
-158.67
20.77
23
A
CYS
81
58.93
15.04
23
A
HIS
84
-48.40
105.33
model building
X-PLOR
3.1
refinement
X-PLOR
3.1
phasing
X-PLOR
3.1
FACTOR VII
N-TERMINAL EGF-LIKE DOMAIN FROM HUMAN FACTOR VII, NMR, 23 STRUCTURES
1
Y
N
A
ASP
48
A
ASP
4
HELX_P
A
SER
52
A
SER
8
5
1
5
disulf
2.020
A
CYS
50
A
SG
CYS
6
1_555
A
CYS
61
A
SG
CYS
17
1_555
disulf
2.019
A
CYS
55
A
SG
CYS
11
1_555
A
CYS
70
A
SG
CYS
26
1_555
disulf
2.019
A
CYS
72
A
SG
CYS
28
1_555
A
CYS
81
A
SG
CYS
37
1_555
BLOOD COAGULATION
BLOOD COAGULATION, EGF, HYDROLASE, SERINE PROTEASE
FA7_HUMAN
UNP
1
1
P08709
MVSQALRLLCLLLGLQGCLAAGGVAKASGGETRDMPWKPGPHRVFVTQEEAHGVLHRRRRANAFLEELRPGSLERECKEE
QCSFEEAREIFKDAERTKLFWISYSDGDQCASSPCQNGGSCKDQLQSYICFCLPAFEGRNCETHKDDQLICVNENGGCEQ
YCSDHTGTKRSCRCHEGYSLLADGVSCTPTVEYPCGKIPILEKRNASKPQGRIVGGKVCPKGECPWQVLLLVNGAQLCGG
TLINTIWVVSAAHCFDKIKNWRNLIAVLGEHDLSEHDGDEQSRRVAQVIIPSTYVPGTTNHDIALLRLHQPVVLTDHVVP
LCLPERTFSERTLAFVRFSLVSGWGQLLDRGATALELMVLNVPRLMTQDCLQQSRKVGDSPNITEYMFCAGYSDGSKDSC
KGDSGGPHATHYRGTWYLTGIVSWGQGCATVGHFGVYTRVSQYIEWLQKLMRSEPRPGVLLRAPFP
105
145
1BF9
45
85
P08709
A
1
1
41
2
2
anti-parallel
anti-parallel
A
SER
60
A
SER
16
A
ASP
63
A
ASP
19
A
TYR
68
A
TYR
24
A
PHE
71
A
PHE
27
A
PHE
76
A
PHE
32
A
GLU
77
A
GLU
33
A
THR
83
A
THR
39
A
HIS
84
A
HIS
40
1
P 1